NovoCure News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.05.19	FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma (Businesswire)
14.05.19	Novocure mit 13 Präsentationen und einem Symposium zu Tumortherapiefeldern auf der 70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie vertreten (Businesswire)
14.05.19	Novocure Announces 13 Presentations and a Symposium on Tumor Treating Fields at the 70th Annual Meeting of the German Society of Neurosurgery (Businesswire)
10.05.19	Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma (Businesswire)
02.05.19	Novocure Reports First Quarter 2019 Financial Results and Provides Company Update (Businesswire)
30.04.19	Ausblick: NovoCure stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
15.04.19	Novocure Publishes 2018 Annual Report Featuring Company’s Vision, Mission and Values (Businesswire)
03.04.19	Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced at AACR Annual Meeting 2019 (Businesswire)
02.04.19	Novocure to Report First Quarter 2019 Financial Results (Businesswire)
22.03.19	Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer (Businesswire)
21.03.19	Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019 (Businesswire)
21.03.19	Novocure’s Chief Science Officer Retires after 17 Years of Service (Businesswire)
18.03.19	Novocure to Participate in Oppenheimer’s 29th Annual Healthcare Conference (Businesswire)
28.02.19	Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update (Businesswire)
26.02.19	Ausblick: NovoCure gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
07.01.19	Novocure Announces Fourth Quarter and Full Year 2018 Operating Statistics, Preliminary Net Revenues and Provides Company Update (Businesswire)
21.12.18	Novocure to Participate in the 37th Annual J.P. Morgan Healthcare Conference (Businesswire)
17.12.18	Novocure and the AACR Announce Four Inaugural Research Grants to Promote and Support Innovative Research on Tumor Treating Fields (Businesswire)
06.12.18	Sub-Group Analysis of Novocure’s EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology Demonstrating More Time on Optune® Predicted Increased Survival (Businesswire)
14.11.18	Novocure and Zai Lab Awarded Deal of the Year at 5th Annual BioCentury China Healthcare Summit in Shanghai, China (Businesswire)
13.11.18	Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology (Businesswire)
07.11.18	Novocure and Zai Lab to Host Investor Event (Businesswire)
26.10.18	ALGN Plunges, NVCR's Q3 Revenue Lags Estimate, SELB Continues To Bleed (RTTNews)
25.10.18	Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update (Businesswire)
24.10.18	Novocure Founder Professor Yoram Palti and Director Louis J. Lavigne, Jr. Retire from Board of Directors (Businesswire)
23.10.18	Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma (Businesswire)
23.10.18	Ausblick: NovoCure veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
22.10.18	Pancreatology Publishes Results of the PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields (Businesswire)
18.10.18	Novocure Announces that the Medicare DME MACs Have Accepted the Local Coverage Determination Reconsideration Request for Optune® (Businesswire)
04.10.18	Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018 (Businesswire)
01.10.18	Novocure to Report Third Quarter 2018 Financial Results (Businesswire)
25.09.18	Data from STELLAR Registration Trial of Tumor Treating Fields in Mesothelioma to be Presented at the IASLC 19th World Conference on Lung Cancer (Businesswire)
22.09.18	Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) (RTTNews)
12.09.18	Novocure and Zai Lab Announce Strategic Collaboration with a License Agreement for Tumor Treating Fields in Greater China (Businesswire)
15.08.18	Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer (Businesswire)
03.08.18	Novocure to Present at Two Upcoming Investor Conferences (Businesswire)
02.08.18	Novocure Announces Addition to Its Board of Directors (Businesswire)
26.07.18	Novocure Reports Second Quarter 2018 Financial Results and Provides Company Update (Businesswire)
19.07.18	Novocure Announces 13 Presentations at American Society for Radiation Oncology 2018 Annual Meeting (Businesswire)
17.07.18	Scientific Track Dedicated to Tumor Treating Fields at 40th International Conference of the IEEE Engineering in Medicine and Biology Society (Businesswire)
02.07.18	Novocure Appoints Pritesh Shah as Chief Commercial Officer (Businesswire)
02.07.18	Novocure to Report Second Quarter 2018 Financial Results (Businesswire)
04.06.18	Novocure to Present INNOVATE-3 Phase 3 Pivotal Trial Design in Recurrent Ovarian Cancer at the American Society of Clinical Oncology Annual Meeting 2018 (Businesswire)
31.05.18	Novocure Announces Changes to Its Board of Directors (Businesswire)
26.04.18	Novocure Reports First Quarter 2018 Financial Results and Provides Company Update (Businesswire)
18.04.18	GWPH Faces FDA Panel Today, NVCR Reports STELLAR Data, 1st XLH Drug Cleared (RTTNews)
17.04.18	Novocure Reports Positive Top-line Results from STELLAR Phase 2 Pilot Trial in Mesothelioma (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.55	2.53 %	K V
Lonza Grp	529.00	1.46 %	K V
Swiss Re	129.80	1.17 %	K V
Logitech Intl	71.66	0.90 %	K V
UBS Group	28.37	0.25 %	K V
Alcon	76.06	-0.81 %	K V
Swiss Life Hldg	727.60	-0.82 %	K V
Givaudan	3’900.00	-0.84 %	K V
Novartis	92.38	-1.39 %	K V
Sonova Hldg	306.30	-1.86 %	K V

Nachrichten zu NovoCure Limited

Aktien Top/Flop

Meistgelesene Nachrichten